SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 75.48+1.4%Nov 14 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (692)2/13/2005 6:50:03 PM
From: CapitalistHogg™  Read Replies (1) of 3722
 
This is nice. Should get a nice pop on ENCY Monday. I hope it is good news.

-- PRESS RELEASE: Encysive Pharmaceuticals Announces Plans to Release Topline Data --

Encysive Pharmaceuticals Announces Plans to Release Topline Data From STRIDE-2
Clinical Trial

HOUSTON, Feb. 11 /PRNewswire-FirstCall/ -- Encysive Pharmaceuticals
(Nasdaq: ENCY) today announced plans to release topline data from STRIDE-2,
the Company's Phase III pivotal clinical trial of Thelin(TM) (sitaxsentan) in
patients with pulmonary arterial hypertension (PAH), on Monday morning,
February 14, 2005. The Company will hold a live investor presentation in
Manhattan to be made accessible via teleconference and webcast, beginning at
8:15 a.m. EST.
Investors are invited to attend the presentation at the Four Seasons
Hotel, 57 E. 57th Street New York, NY (Cosmopolitan Suite).
To participate via teleconference, dial 1-800-901-5213; passcode 53735498.
The presentation can also be monitored via the internet at
encysive.com .
A replay of the webcast will be available on the Company's website through
Monday, March 14, 2005. A replay of the call can also be accessed until the
same date by dialing 1-888-286-8010; passcode 76025230.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News